Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...
The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...
The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients ...
A second study has linked semaglutide, the active ingredient in Ozempic, to a condition that can cause permanent vision loss.
Their symptom improvement was likely thanks to their weight loss, the FDA said. Zepbound is a glucagon-like peptide 1 drug that reduces appetite and food intake. The drug's active ingredient, ...
One lawmaker said the CT Department of Social Services told him the agency wasn’t paying for FDA-approved drugs because of ...
The U.S. Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the ...
HealthDay on MSN1d
2023 Saw Decline in BMI, Obesity Prevalence in the United StatesBody mass index (BMI) and obesity prevalence declined in the United States in 2023, according to a research letter published ...
Elected officials are looking to expand access to weight loss drugs like Ozempic and Wegovy for low-income Virginians as part ...
The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...
The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...
Health and Me on MSN1d
This Popular Weight Loss Drug Can Now Be Used To Treat Sleep ApneaZepbound is the first medication approved to treat people with obstructive sleep apnea, said Sailly Seymor, director of FDA's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback